Trends in Neurosciences
ReviewNeurotransmitter receptors on microglia
Introduction
Microglia are present in all regions of the central nervous system (CNS), although their density varies in different brain regions [1]. Microglia, first described by Río- Hortega [2] and characterized by a small soma and several highly branched processes, are derived from the myelomonocytic lineage and invade the CNS tissue at both embryonic and postnatal stages (for reviews, see 3, 4). These microglial precursors possess an ameboid morphology and actively migrate within the brain parenchyma to colonize all regions of the brain. Microglia acquire a highly ramified morphology in the healthy adult brain; microglia in this form are termed ‘resting microglia’. [5]. When one observes the morphology of resting microglia, it is evident that each cell has a territory that it covers with its highly branched processes. Two recent reports have noted that these processes are highly motile; in fact, they are the most dynamic structures in the CNS 6, 7. This process movement could be viewed as a constant survey of the microglial cell's territory, and these cells should perhaps be termed ‘surveying’ than ‘resting’ microglia (Figure 1, Figure 2, Figure 3).
The majority of previous studies on microglia have been concerned with their role in pathology (for a review, see [3]). Microglia are the first elements to respond after any kind of disturbance in the brain. They undergo a transformation, also termed microglial activation, that can happen within a few hours and last many days. One feature of this activation process is the transformation of the cells into an ameboid morphology that is similar to that of the initial infiltrating precursors. Depending on the pathologic stimulus, the activated microglia might proliferate, migrate toward injured or damaged areas and/or be induced to release many factors, such as cytokines or reactive oxygen species (ROS), that affect the pathologic process. Microglia are antigen-presenting cells because they express proteins of the MHC-II complex and are, thereby, interaction partners with infiltrating T lymphocytes. They express a wide array of characteristic immune-cell receptors, such as chemokine and cytokine receptors and receptors of the complement-factor family. Thus, microglia have been viewed as intrinsic immune cells, but they have not been considered as normal communication partners within the neuronal network. Functional synapses have recently been discovered on subtypes of astrocytes [8], but there is no evidence so far to suggest that microglia might receive synaptic input.
In the following discussion, we will, however, summarize the evidence that microglia can express a variety of different classical neurotransmitter receptors that were originally thought to be specific for neurons but in the interim have been widely described in macroglial cells (astrocytes and oligodendrocytes). Synaptic structures are missing on microglia, so how can microglial transmitter receptors be activated? In 1995, Agnati and Fuxe proposed a model of ‘volume transmission’, as opposed to ‘wiring transmission’ 9, 10. In this model, neuroactive substances are not only strictly confined to the synaptic cleft but can also diffuse in the extracellular space and activate extrasynaptic receptors. Indeed, neurons express transmitter receptors not only at the postsynaptic density but also at the presynapse and other regions of the cell. It has been recognized that these extrasynaptic receptors serve many regulatory roles in the neuronal network. This makes it increasingly likely that neurotransmitter receptors are also activated on microglia because of the diffusion of transmitters in the extracellular space.
Section snippets
Ionotropic glutamate receptors (iGluRs) can modulate tumour-necrosis factor α (TNFα) release
Glutamate is the major excitatory neurotransmitter of the CNS, and pertubations in the homeostasis of this transmitter have been reported in neurodegenerative diseases. The main functional iGluRs in cultured rat microglia are mostly AMPA (D,L-α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type GluRs (GluRs 1–3, mainly in the flip form) rather than kainate receptors 11, 12. Whereas glutamate or kainate can trigger TNFα release, AMPA receptor agonists inhibit it; unexpectedly,
Metabotropic glutamate receptors (mGluRs) mediate neurotoxicity and neuroprotection
Microglia express mGluRs, and stimulation by different subtypes of mGluRs can transform microglia into a neuroprotective (via group III mGluRs) or neurotoxic (via group II mGluRs) phenotype (Figure 3) 14, 15, 16, 17. The direct activation of group II mGluRs, particularly mGluR2, induces microglial stress (mitochondrial depolarization and apoptosis) 15, 18 and neurotoxicity [17]. The toxicity of microglial mGluR2 stimulation involves the microglial release of TNFα and FasL (Fas ligand), which
GABAB receptors modulate interleukin (IL) release
GABA (gamma-amino-butyric acid, also known as γ-aminobutyric acid) can act as a neuroprotective agent in addition to playing a well-established role as the main inhibitory neurotransmitter in the CNS. All three principle GABAB receptors are expressed by microglia in situ and in culture [22]. GABAB receptor stimulation leads to the activation of a K+ conductance in cultured microglia and in acute brain slices, and microglial activation leads to an increase in the expression of GABAB receptors in
Purinergic receptors control migration and cytokine release
ATP induces a rapid microglial activation in response to local brain injury in vivo [6], and microglia express a variety of purinergic receptors (Table 1) 23, 24, 25. Purinoreceptors control several properties of microglia, including the motility of their fine processes, the release of cytokines, migration and phagocytosis (Figure 2) 26, 27, 28, 29. ATP triggers a rapid physiological response, the activation of cationic and potassium conductance and an increase in intracellular calcium (for a
Adenosine receptors play a dual role
The neuroprotective effect of adenosine might be linked to the release of neurotrophic factors, such as nerve growth factor (NGF), via the activation of A2a receptors (Figure 3) [44]. However, activation of microglial A2a receptors also induces the expression of COX (cyclooxygenase)-2 mRNA, the synthesis of prostaglandin E2 (PGE2) [45] and the potentiation of nitric oxide (NO) release from activated microglia. This suggests that the specific attenuation of microglial A2a receptors might
Adrenergic, dopmaninergic and cholinergic receptors exhibit anti-inflammatory effects
Functional noradrenergic and dopaminergic receptors modulate membrane currents in microglia in acutely isolated brain slices [48]. Beta-adrenergic agonists inhibit PMA (phorbol 12-myristate 13-acetate)-induced SO production [49] and LPS-induced IL-12p40 release [50] and suppress microglial proliferation (Figure 3) [51]. Stimulation of adrenergic receptors decreases cytokine and NO expression and release 48, 52, 53. Chronic application of dopamine also attenuates LPS-induced NO release but not
Cannabinoid receptors mediate neuroprotection
Activated microglia express CB2 cannabinoid receptors when their expression in the normal brain is very low (for a review, see [59]). Activation of the microglial CB2 receptor stimulates microglial migration [60] and proliferation [61], and the receptor works in concert with the abnormal-cannabidiol-sensitive receptor to modulate microglial migration (Figure 2) [60]. Activation of CB1 mediates inhibition of NO production by rat microglia [62], although the proposed intracellular location of CB1
Opioid receptors on microglia and their involvement in Parkinsońs disease, Alzheimeŕs disease and HIV dementia
Of the three classes of opioid receptors (delta [δ], mu [μ] and kappa [κ]) so far identified, microglia express μ-opioid receptors (MORs) and κ-opioid receptors (KORs) but not δ receptors, and they also express a third, seemingly opioid-receptor-independent pathway for the activity of endogenous opioid-receptor ligands, such as dynophin. MOR3 activation triggers morphological changes and brain-derived neurotrophic factor (BDNF) expression 71, 72 and inhibits microglial chemotaxis and migration,
Neuropeptides can be pro- and anti-inflammatory
Evidence suggests that the tachykinin substance P augments proinflammatory responses in microglia. Microglia can express substance P [81] and its receptor, neurokinin-1 (NK-1), suggesting an autocrine loop for substance P signalling in microglia. Substance P can stimulate chemotaxis at low concentrations of only 10 nM via an NK-1-mediated pathway and activate the transcriptional factor NF-κB [82] and microglial NADPH oxidase; the activation of microglial NADPH leads to the generation of
Conclusion
It is evident that microglia express a variety of neurotransmitter receptors and that these receptors control microglial functions. One could speculate that, during normal brain function, extrasynaptic neurotransmitters signal to microglia that neurons are active and thereby suppress microglial activation. Essentially, all the known functions of microglia are linked to pathology, and this implies that neurotransmitters can influence pathologic processes via microglia. One of the major handicaps
References (95)
Intercellular communication in the brain: wiring versus volume transmission
Neurosci.
(1995)Volume transmission in the CNS and its relevance for neuropsychopharmacology
Trends Pharmacol. Sci.
(1999)Microglia express GABAB receptors to modulate interleukin release
Mol. Cell. Neurosci.
(2004)- et al.
P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system
Eur. J. Pharmacol.
(2002) Pathophysiological roles of extracellular nucelotides in glial cells; differential expression of purinergic receptors in resting and activated microglia
Brain Res. Brain Res. Rev.
(2005)ATP-mediated cytotoxicity in microglial cells
Neuropharm.
(1997)Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2Y receptors
Brain Res.
(2003)Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia
J. Neurosci.
(2004)P2X7 mediates superoxide production in primary microglia and is upregulated in a transgenic mouse model of Alzheimer‘s disease
J. Biol. Chem.
(2003)The function of microglia through purinergic receptors; Neuropathic pain and cytokine release
Pharmacol. Ther.
(2006)
Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors
Neurosci. Lett.
Activation of adenosine A(3) receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI13-kinase/Akt and NfkappaB activation in murine BV2 microglial cells
Neurosci. Lett.
Dopamine and noradrenaline control distinct functions in rodent microglial cells
Mol. Cell. Neurosci.
Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone
Neurochem. Int.
β-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia
Brain Res.
Adrenergic agonists suppress the proliferation of microglia through β2-adrenergic receptor
Neurosci. Lett.
Effects of norepinephrine on rat cultured microglial cells that express α1, α2, β1 and β2 adrenergic receptors
Neuropharm.
Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120
Brain Res. Bull.
Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors
Eur. J. Pharmacol.
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
Neuron
Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells
Brain Res.
Morphine induces apoptosis of human microglia and neurons
Neuropharmacol.
U50488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression
Neuropharmacol.
Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase
Neuropeptides
Detection of substance P and its receptor in human fetal microglia
Neurosci.
Expression and function of bradykinin receptors in microglia
Life Sci.
GABA B receptor subunit expression in glia
Mol. Cell. Neurosci.
Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude
Acta. Neuropathol. (Berl.).
El tercer elemento de los centros nerviosos
Bol. Soc. Esp. Biol.
Microglia
Metab. Brain Dis.
Microglia in health and disease
J. Neurosci. Res.
Microglia as neuroprotective, immunocompetent cells of the CNS
Glia
ATP mediates rapid microglial responses to local brain injury in vivo
Nat. Neurosci.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Science
Synaptic signaling between neurons and glia
Glia
AMPA-kainate subtype of glutamate receptor in rat cerebral microglia
J. Neurosci.
Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia
Glia
Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischaemia
J. Cereb. Blood Flow Metab.
Expression and signalling of group I metabotropic glutamate receptors in astrocytes and microglia
J. Neurochem.
Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease
J. Neurochem.
Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity
J. Neurosci.
Stimulation of microglial metabotopic glutamate receptor, mGlu2 triggers TNFα-induced neurotoxicity in concert with microglial derived FasL
J. Neurosci.
Microglial apoptosis induced by chromogranin A is mediated by a mitochondrial depolarisation and the permeability transition but not by cytochrome c release
J. Neurochem.
Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation
J. Neurochem.
The metabotropic glutamate receptors: structure and functions
Neurosci. Lett.
Baseline glutamate levels affect group I and II mGluRs in layer V pyramidal neurons of rat sensorimotor cortex
J. Neurophysiol.
Characterisation and possible function of adenosine 5′-triphosphate receptors in activated rat microglia
Br. J. Pharmacol.
Cited by (528)
Tuning neural circuits and behaviors by microglia in the adult brain
2024, Trends in NeurosciencesTOM40 mediates the effect of TSPO on postpartum depression partially through regulating calcium homeostasis in microglia
2024, Journal of Affective DisordersOxytocin as a neuroprotective strategy in neonates: concept and preclinical evidence
2024, Gynecologie Obstetrique Fertilite et SenologieTranscriptional and epigenetic regulation of microglia in substance use disorders
2023, Molecular and Cellular Neuroscience